U.S. deal could cut costs for popular weight-loss drugs. What's that mean for Canada?
  • Nov 06, 2025

U.S. deal could cut costs for popular weight-loss drugs. What's that mean for Canada?

  • CBC News
Medicare can now cover weight loss drugs like Ozempic, Trump announces
  • Nov 06, 2025

Medicare can now cover weight loss drugs like Ozempic, Trump announces

  • Axios
Blood Tests for Alzheimer's Are Here
  • Nov 05, 2025

Blood Tests for Alzheimer's Are Here

  • Wired
Cancer Drug Made 20,000 Times More Potent in Breakthrough
  • Nov 05, 2025

Cancer Drug Made 20,000 Times More Potent in Breakthrough

  • Newsweek
Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole
  • Nov 04, 2025

Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole
A miracle pill for Parkinson’s is 50 years old. Why can’t most of the world get it?
  • Nov 04, 2025

A miracle pill for Parkinson’s is 50 years old. Why can’t most of the world get it?

  • STAT
Shortage of prescription painkillers in Canada expected to last until 2026
  • Nov 04, 2025

Shortage of prescription painkillers in Canada expected to last until 2026

  • CBC News
Canada's prescription painkiller shortage expected to continue into 2026
  • Nov 04, 2025

Canada's prescription painkiller shortage expected to continue into 2026

  • CTV News
Myeloma patients launch campaign for immunotherapy pricing talks to resume
  •  —
  • Nov 03, 2025

Myeloma patients launch campaign for immunotherapy pricing talks to resume

  • The Globe and Mail
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
  • Nov 03, 2025

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

  • Global News
Lobby Wrap: GlaxoSmithKline wants to talk about vaccines and other issues
  • Nov 03, 2025

Lobby Wrap: GlaxoSmithKline wants to talk about vaccines and other issues
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk
  • Nov 01, 2025

Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk

  • The Canadian Press
Why a $20 European eye drop costs $800-a-month in the U.S.
  • Nov 01, 2025

Why a $20 European eye drop costs $800-a-month in the U.S.

  • STAT
FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical
  • Nov 01, 2025

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

  • The Canadian Press
Eli Lilly's weight loss, diabetes drug tops Keytruda as world's best-selling medicine
  • Nov 01, 2025

Eli Lilly's weight loss, diabetes drug tops Keytruda as world's best-selling medicine

  • STAT
Canadians can wait years to get drugs regulators have already deemed safe. Why?
  •  —
  • Oct 31, 2025

Canadians can wait years to get drugs regulators have already deemed safe. Why?

  • The Globe and Mail
Indian pharma giant says Health Canada rejected its application to make generic semaglutide
  •  —
  • Oct 30, 2025

Indian pharma giant says Health Canada rejected its application to make generic semaglutide

  • The Globe and Mail
FDA plans to speed approvals of biosimilars
  • Oct 30, 2025

FDA plans to speed approvals of biosimilars

  • Axios
What we know about the Alzheimer's drug Health Canada approved
  • Oct 29, 2025

What we know about the Alzheimer's drug Health Canada approved

  • CBC News
Trump and RFK Jr. trigger legal war that could drive vaccine makers from U.S.
  • Oct 29, 2025

Trump and RFK Jr. trigger legal war that could drive vaccine makers from U.S.

  • Axios
Excitement around Alzheimer's treatment tempered by questions about efficacy, accessibility
  •  —
  • Oct 28, 2025

Excitement around Alzheimer's treatment tempered by questions about efficacy, accessibility

  • The Globe and Mail
New treatment gives hope to patients with early Alzheimer's disease
  • Oct 28, 2025

New treatment gives hope to patients with early Alzheimer's disease

  • CBC News
Texas sues Tylenol, claims companies hid autism risks
  • Oct 28, 2025

Texas sues Tylenol, claims companies hid autism risks

  • Global News
If a mine is a nation-building project, why not universal pharmacare? Inside the big push to get Mark Carney behind it
  • Oct 27, 2025

If a mine is a nation-building project, why not universal pharmacare? Inside the big push to get Mark Carney behind it

  • Toronto Star
Canada approves expensive new drug that can slow Alzheimer’s
  • Oct 27, 2025

Canada approves expensive new drug that can slow Alzheimer’s

  • CTV News
Antidepressants cause weight gain, blood pressure changes quickly: study
  • Oct 25, 2025

Antidepressants cause weight gain, blood pressure changes quickly: study

  • CTV News
New immunotherapy shows promise for long-term HIV control without daily medication
  • Oct 25, 2025

New immunotherapy shows promise for long-term HIV control without daily medication
Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V. (ustekinumab), a Biosimilar to Stelara®
  • Oct 24, 2025

Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V. (ustekinumab), a Biosimilar to Stelara®
Antidepressant side effects vary depending on the drug
  • Oct 23, 2025

Antidepressant side effects vary depending on the drug
New eczema cream approved by Health Canada offers relief for Alberta patients
  • Oct 22, 2025

New eczema cream approved by Health Canada offers relief for Alberta patients

  • CTV News
Canadian public drug plan spending grew by $3.4 billion over 5 years, driven by use of higher-cost drugs
  • Oct 22, 2025

Canadian public drug plan spending grew by $3.4 billion over 5 years, driven by use of higher-cost drugs

  • Government of Canada
Tylenol maker urges FDA to reject request for an autism warning on labels
  • Oct 21, 2025

Tylenol maker urges FDA to reject request for an autism warning on labels

  • NBC News
Alcohol, nicotine and more — could drugs like Ozempic curb the desire for vices?
  • Oct 21, 2025

Alcohol, nicotine and more — could drugs like Ozempic curb the desire for vices?

  • CBC News
The doctors aren’t ok
  • Oct 20, 2025

The doctors aren’t ok

  • Canada Healthwatch
  •  — 
  • Nick Tsergas
Canadian firm enters race to bring generic Ozempic to market
  •  —
  • Oct 20, 2025

Canadian firm enters race to bring generic Ozempic to market

  • The Globe and Mail
Ontario needs to do better for seniors' vaccines says report card
  • Oct 20, 2025

Ontario needs to do better for seniors' vaccines says report card

  • Elliot Lake News
Ozempic, Wegovy stocks wilt following Trump's GLP-1 comments
  • Oct 17, 2025

Ozempic, Wegovy stocks wilt following Trump's GLP-1 comments

  • Axios
America Is Heavily Reliant on China for Raw Materials in Medicines
  •  —
  • Oct 16, 2025

America Is Heavily Reliant on China for Raw Materials in Medicines

  • The New York Times
False hope, fabricated data: No public notice after UBC uncovered serious misconduct in medical study
  • Oct 15, 2025

False hope, fabricated data: No public notice after UBC uncovered serious misconduct in medical study

  • CBC News
Three things Canada’s health ministers could do to help Canadians with cancer
  • Oct 15, 2025

Three things Canada’s health ministers could do to help Canadians with cancer

Canada’s 14 health ministers will meet this week in Alberta. Given the many challenges facing our health systems, they have a lot to discuss. But what can they actually do to start helping Canadians right away?

  • Sandeep Sehdev and Mita Manna
South Africa's health minister hails new HIV prevention jab but warns of limited supply
  • Oct 15, 2025

South Africa's health minister hails new HIV prevention jab but warns of limited supply

  • Associated Press
'As new infections outpace new drugs, are we sleepwalking into a global health disaster?'
  • Oct 14, 2025

'As new infections outpace new drugs, are we sleepwalking into a global health disaster?'

  • The Guardian

Check out our newsletter, it's a handpicked roundup of the most important news from the week.  Subscribe